5
Apr
2018
Van Andel Research Institute scientists help redefine how cancer is categorized
Comprehensive scientific resource highlighted in more than two dozen papers published in Cell Press by The Cancer Genome Atlas
/
Laird is senior author on the paper, along with Adam J. Bass, M.D., of Harvard University and Dana-Farber Cancer Institute, and Vésteinn... Read More
2
Apr
2018
10
May
2017
Research brief: New understanding of lethal women’s cancer
/
TCGA publishes molecular profile of uterine carcinosarcoma, offers potential new treatment options Researchers from The Cancer Genome Atlas, including Van Andel Research... Read More
17
Nov
2016
Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis
/
GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from... Read More
18
Nov
2015
Van Andel Research Institute’s Hui Shen receives ovarian cancer research award
/
GRAND RAPIDS, Mich. (Nov. 18, 2015)—The Ovarian Cancer Research Fund (OCRF) announced yesterday that Van Andel Research Institute (VARI) Assistant Professor Hui... Read More
5
Nov
2015
TCGA findings provide molecular background for second most common kidney cancer
/
GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have molecularly characterized two... Read More
2
Sep
2014
Van Andel Research Institute names new assistant professor as part of epigenetics expansion
/
Grand Rapids, Mich. (Sept. 2, 2014) – Van Andel Research Institute (VARI) has added to its rapidly expanding epigenetics hub with the appointment... Read More